These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 12881870)

  • 1. [Effects of atenolol and diltiazem-SR on quality of life in the hypertensive patients].
    Yao XY; Fan WH; Chen JZ; Zhu JH; Chen BX; Liu XJ
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2003 Jun; 32(3):231-4. PubMed ID: 12881870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of atenolol and diltiazem-SR on exercise and pressure load in hypertensive patients.
    Chrysant SG; Miller E
    Clin Cardiol; 1994 Dec; 17(12):670-4. PubMed ID: 7867240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of diltiazem and atenolol in young, physically active men with essential hypertension.
    Myburgh DP; Gordon NF
    Am J Cardiol; 1987 Nov; 60(13):1092-5. PubMed ID: 3314458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exercise capacity and hemodynamics in persons aged 20 to 50 years with systemic hypertension treated with diltiazem and atenolol.
    Luurila OJ; Gröhn P; Heikkilä J; Hämäläinen L; Härkönen R; Idänpään-Heikkilä U; Kohvakka A; Rytkönen U; Setälä M; Sundberg S
    Am J Cardiol; 1987 Oct; 60(10):832-5. PubMed ID: 3310576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sustained-release diltiazem compared with atenolol monotherapy for mild to moderate systemic hypertension.
    Weir MR; Josselson J; Giard MJ; Warren JB; Posner JN; Lam YW; Zaske DE; Saunders E
    Am J Cardiol; 1987 Dec; 60(17):36I-41I. PubMed ID: 3318375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of verapamil SR and atenolol on 24-hour blood pressure and heart rate in hypertension patients with coronary artery disease: an international verapamil SR-trandolapril ambulatory monitoring substudy.
    Denardo SJ; Gong Y; Cooper-DeHoff RM; Farsang C; Keltai M; Szirmai L; Messerli FH; Bavry AA; Handberg EM; Mancia G; Pepine CJ
    PLoS One; 2015; 10(4):e0122726. PubMed ID: 25835002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized controlled trial of the effects of three antihypertensive agents on blood pressure control and quality of life in older women.
    Applegate WB; Phillips HL; Schnaper H; Shepherd AM; Schocken D; Luhr JC; Koch GG; Park GD
    Arch Intern Med; 1991 Sep; 151(9):1817-23. PubMed ID: 1888248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diltiazem and atenolol in essential hypertension: additivity of effects on blood pressure and cardiac conduction with combination therapy.
    Tonkin AL; Wing LM; Russell AE; West MJ; Bune AJ; Morris MJ; Cain MD; Chalmers J
    J Hypertens; 1990 Nov; 8(11):1015-9. PubMed ID: 1963183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Twenty-four-hour ambulatory blood pressure monitoring efficacy of perindopril/indapamide first-line combination in hypertensive patients: the REASON study.
    Mallion JM; Chamontin B; Asmar R; De Leeuw PW; O'Brien E; Duprez D; O'Rourke MF; Rahn KH; Romero R; Battegay E; Hitzenberger G; Safar ME;
    Am J Hypertens; 2004 Mar; 17(3):245-51. PubMed ID: 15001199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of diltiazem and atenolol in angina.
    Wheatley D
    Postgrad Med J; 1985 Sep; 61(719):785-9. PubMed ID: 3903709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the efficacy and tolerability of an angiotensin converting enzyme inhibitor (lisinopril) versus a calcium channel antagonist (diltiazem SR) in the treatment of moderate to severe hypertension.
    Weir MR; Fagan T; Chrysant S; Flamenbaum W; Kaihlanen PM; Lueg M; Anzalone D
    J Hum Hypertens; 1994 Jul; 8(7):531-7. PubMed ID: 7932518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of bisoprolol and atenolol in patients with mild to moderate hypertension: a double-blind, parallel group international multicentre study.
    Lithell H; Selinus I; Hosie J; Frithz G; Weiner L
    Eur Heart J; 1987 Dec; 8 Suppl M():55-64. PubMed ID: 2967186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of diltiazem and metoprolol on blood pressure, adverse symptoms and general well-being. The Swedish Diltiazem-Metoprolol Multi-Centre Study Group.
    Dahlöf C; Hedner T; Thulin T; Gustafsson S; Olsson SO
    Eur J Clin Pharmacol; 1991; 40(5):453-60. PubMed ID: 1884720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of therapeutic mechanisms of atenolol and diltiazem in patients with variable-threshold angina.
    Nadazdin A; Davies GJ
    Am Heart J; 1994 Feb; 127(2):312-7. PubMed ID: 8296698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Twenty-four hour ambulatory blood pressure profile of a new slow-release formulation of diltiazem in mild to moderate hypertension.
    Dupont AG; Coupez JM; Jensen P; Coupez-Lopinot R; Schoors DF; Hermanns P; Nicolas M
    Cardiovasc Drugs Ther; 1991 Aug; 5(4):701-7. PubMed ID: 1888693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transdermal clonidine as an adjunct to sustained-release diltiazem in the treatment of mild-to-moderate hypertension.
    Lueg MC; Herron J; Zellner S
    Clin Ther; 1991; 13(4):471-81. PubMed ID: 1933999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiopulmonary response during exercise of a beta 1-selective beta-blocker (atenolol) and a calcium-channel blocker (diltiazem) in untrained subjects with hypertension.
    Cohen-Solal A; Baleynaud S; Laperche T; Sebag C; Gourgon R
    J Cardiovasc Pharmacol; 1993 Jul; 22(1):33-8. PubMed ID: 7690093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diltiazem compared with metoprolol as add-on-therapies to diuretics in hypertension. Swedish Diltiazem-Metoprolol Multicentre Study Group.
    Thulin T; Hedner T; Gustafsson S; Olsson SO
    J Hum Hypertens; 1991 Apr; 5(2):107-14. PubMed ID: 2072368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trough-to-peak ratio and circadian blood pressure profile after treatment with once-daily extended-release diltiazem, 240 mg, in patients with mild-to-moderate essential hypertension.
    Coca A; Sobrino J; Soler J; Módol J; Palos MA; Mínguez A; Esqúe J; Plana J; Cases M; Closas J; de la Sierra A
    J Cardiovasc Pharmacol; 1997 Mar; 29(3):316-22. PubMed ID: 9125668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term effects of diltiazem and atenolol on blood glucose, serum lipids, and serum urate in hypertensive patients. Swedish-Finnish Study Group.
    Thulin T; Lehtonen A; Dahlöf C; Nilsson-Ehle P; Engqvist L; Lagerstedt C; Berglund E
    Int J Clin Pharmacol Ther; 1999 Jan; 37(1):28-33. PubMed ID: 10027480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.